These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7657279)

  • 21. Mannitolum infusion on cirrhotic patients with tense ascites treated by paracentesis.
    Zhao J; Yuan C; Wang D; Li X
    Chin Med J (Engl); 2000 Jan; 113(1):27-30. PubMed ID: 11775204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of dopamine on hemodynamic and hormonal parameters in liver cirrhosis].
    Tesar V; Petrtýl J; Jedlicka J; Horký K; Gregorová I; Kopecká J; Marek J; Marecek Z; Kordac V
    Cas Lek Cesk; 1990 Apr; 129(17):520-5. PubMed ID: 2140956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites.
    Pozzi M; Osculati G; Boari G; Serboli P; Colombo P; Lambrughi C; De Ceglia S; Roffi L; Piperno A; Cusa EN
    Gastroenterology; 1994 Mar; 106(3):709-19. PubMed ID: 8119542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
    Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
    Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.
    Quiroga J; Sangro B; Núñez M; Bilbao I; Longo J; García-Villarreal L; Zozaya JM; Betés M; Herrero JI; Prieto J
    Hepatology; 1995 Apr; 21(4):986-94. PubMed ID: 7705810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large-volume paracentesis and intravenous saline: effects on the renin-angiotensin system.
    Cabrera J; Inglada L; Quintero E; Jimenez W; Losada A; Mayor J; Guerra C
    Hepatology; 1991 Dec; 14(6):1025-8. PubMed ID: 1959849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study.
    Singh V; Dheerendra PC; Singh B; Nain CK; Chawla D; Sharma N; Bhalla A; Mahi SK
    Am J Gastroenterol; 2008 Jun; 103(6):1399-405. PubMed ID: 18547224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.
    Fernández J; Monteagudo J; Bargallo X; Jiménez W; Bosch J; Arroyo V; Navasa M
    Hepatology; 2005 Sep; 42(3):627-34. PubMed ID: 16108036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
    Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
    Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites.
    Okumura H; Aramaki T; Katsuta Y; Satomura K; Akaike M; Sekiyama T; Terada H; Ohsuga M; Komeichi H; Tsutsui H
    Am J Gastroenterol; 1991 Jan; 86(1):46-52. PubMed ID: 1986554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis.
    Bandi JC; García-Pagán JC; Escorsell A; François E; Moitinho E; Rodés J; Bosch J
    Hepatology; 1998 Sep; 28(3):677-82. PubMed ID: 9731558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis.
    Ruiz-del-Arbol L; Monescillo A; Jimenéz W; Garcia-Plaza A; Arroyo V; Rodés J
    Gastroenterology; 1997 Aug; 113(2):579-86. PubMed ID: 9247479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of albumin infusion in decompensated liver cirrhosis].
    Schmidt LE; Ring-Larsen H
    Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
    Blendis LM; Greig PD; Langer B; Baigrie RS; Ruse J; Taylor BR
    Gastroenterology; 1979 Aug; 77(2):250-7. PubMed ID: 447039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large-volume paracentesis versus dialytic ultrafiltration in the treatment of cirrhotic ascites.
    Lai KN; Li P; Law E; Swaminathan R; Nicholls MG
    Q J Med; 1991 Jan; 78(285):33-41. PubMed ID: 1670062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
    Albillos A; Lledó JL; Bañares R; Rossi I; Iborra J; Calleja JL; Garrido A; Escartin P; Bosch J
    Hepatology; 1994 Sep; 20(3):611-7. PubMed ID: 7915703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.